- Home
- FE vs PODD Comparison
FE vs PODD Comparison
Compare FE & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FE
- PODD
- Stock Information
- Founded
- FE 1996
- PODD 2000
- Country
- FE United States
- PODD United States
- Employees
- FE N/A
- PODD N/A
- Industry
- FE Electric Utilities: Central
- PODD Medical/Dental Instruments
- Sector
- FE Utilities
- PODD Health Care
- Exchange
- FE Nasdaq
- PODD Nasdaq
- Market Cap
- FE 23.9B
- PODD 23.8B
- IPO Year
- FE N/A
- PODD 2007
- Fundamental
- Price
- FE $43.55
- PODD $327.80
- Analyst Decision
- FE Buy
- PODD Strong Buy
- Analyst Count
- FE 16
- PODD 18
- Target Price
- FE $46.14
- PODD $334.50
- AVG Volume (30 Days)
- FE 3.2M
- PODD 568.2K
- Earning Date
- FE 10-28-2025
- PODD 11-06-2025
- Dividend Yield
- FE 4.10%
- PODD N/A
- EPS Growth
- FE 49.18
- PODD N/A
- EPS
- FE 2.27
- PODD 3.32
- Revenue
- FE $13,864,000,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- FE $8.73
- PODD $29.18
- Revenue Next Year
- FE $3.41
- PODD $18.09
- P/E Ratio
- FE $19.12
- PODD $96.84
- Revenue Growth
- FE 6.52
- PODD 26.00
- 52 Week Low
- FE $37.58
- PODD $225.37
- 52 Week High
- FE $44.58
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- FE 54.08
- PODD 47.77
- Support Level
- FE $43.05
- PODD $313.24
- Resistance Level
- FE $43.93
- PODD $351.94
- Average True Range (ATR)
- FE 0.49
- PODD 10.28
- MACD
- FE -0.07
- PODD -3.57
- Stochastic Oscillator
- FE 61.32
- PODD 35.20
About FE FirstEnergy Corp.
FirstEnergy is an investor-owned holding company with 10 regulated distribution utilities across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.